All stock lists
Unlock the score
Nuo Therapeutics, Inc. (AURX)
United States · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.30+0.00 (+0.00%)
Insider Score
/ 100
AURX Insider Score
Nuo Therapeutics, Inc. has a live Insider Score.
Scored on 2 qualifying trades from 1 insider in the last 90 days.
AURX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 1.77 M | 1.30 M | 1.10 M | 700.20 K | 484.38 K |
| Revenue Growth (YoY) | 265.21 % | — | — | — | — |
| Cost of Revenue | 598.96 K | 452.39 K | 408.46 K | 159.35 K | 121.02 K |
| Gross Profit | 1.17 M | 849.73 K | 688.37 K | 540.85 K | 363.36 K |
| SG&A Expense | 1.34 M | 1.30 M | 1.27 M | 1.19 M | 1.11 M |
| R&D Expense | — | — | — | — | — |
| Operating Expenses | 1.34 M | 1.30 M | 1.27 M | 1.19 M | 1.11 M |
| Operating Income | -166.55 K | -446.47 K | -579.34 K | -652.02 K | -745.15 K |
| Pretax Income | -277.60 K | -618.47 K | -578.48 K | -649.69 K | -746.13 K |
| Tax Provision | — | — | — | — | — |
| Net Income | -277.60 K | -618.47 K | -578.48 K | -649.69 K | -746.13 K |
| EPS (Basic) | -0.01 | -0.01 | — | -0.01 | -0.02 |
| EPS (Diluted) | -0.01 | -0.01 | — | -0.01 | -0.02 |
| Shares Outstanding | 48.41 M | 48.29 M | — | 46.82 M | 46.82 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.